LGALS9

Lectin, galactoside-binding, soluble, 9 (galectin 9)
Identifiers
Symbols	LGALS9 ; ECALECTIN; MGC117375; MGC125973; MGC125974; galectin-9
External IDs	Template:OMIM5 Template:MGI HomoloGene: 32078
Gene ontology Molecular function Template:GNF GO Template:GNF GO Template:GNF GO Biological process Template:GNF GO
RNA expression pattern
File:PBB GE LGALS9 203236 s at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a

Lectin, galactoside-binding, soluble, 9 (galectin 9), also known as LGALS9, is a human gene.

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. This galectin is strongly overexpressed in Hodgkin's disease tissue and it might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its consistently associated immunodeficiency. The protein has N- and C- terminal carbohydrate-binding domains connected by a link peptide. Multiple alternatively spliced transcript variants have been found for this gene.

Further reading

• Hirashima M, Kashio Y, Nishi N; et al. (2004). "Galectin-9 in physiological and pathological conditions". Glycoconj. J. 19 (7–9): 593–600. doi:10.1023/B:GLYC.0000014090.63206.2f. PMID 14758084.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
• Türeci O, Schmitt H, Fadle N; et al. (1997). "Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease". J. Biol. Chem. 272 (10): 6416–22. PMID 9045665.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Matsumoto R, Matsumoto H, Seki M; et al. (1998). "Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes". J. Biol. Chem. 273 (27): 16976–84. PMID 9642261.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Matsumoto R, Hirashima M, Kita H, Gleich GJ (2002). "Biological activities of ecalectin: a novel eosinophil-activating factor". J. Immunol. 168 (4): 1961–7. PMID 11823532.CS1 maint: Multiple names: authors list (link)
• Kageshita T, Kashio Y, Yamauchi A; et al. (2002). "Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance". Int. J. Cancer. 99 (6): 809–16. doi:10.1002/ijc.10436. PMID 12115481.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Imaizumi T, Kumagai M, Sasaki N; et al. (2002). "Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells". J. Leukoc. Biol. 72 (3): 486–91. PMID 12223516.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Asakura H, Kashio Y, Nakamura K; et al. (2003). "Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9". J. Immunol. 169 (10): 5912–8. PMID 12421975.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Kashio Y, Nakamura K, Abedin MJ; et al. (2003). "Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway". J. Immunol. 170 (7): 3631–6. PMID 12646627.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Abedin MJ, Kashio Y, Seki M; et al. (2003). "Potential roles of galectins in myeloid differentiation into three different lineages". J. Leukoc. Biol. 73 (5): 650–6. PMID 12714580.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Matsuda A, Suzuki Y, Honda G; et al. (2003). "Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways". Oncogene. 22 (21): 3307–18. doi:10.1038/sj.onc.1206406. PMID 12761501.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Irie A, Yamauchi A, Kontani K; et al. (2005). "Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer". Clin. Cancer Res. 11 (8): 2962–8. doi:10.1158/1078-0432.CCR-04-0861. PMID 15837748.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Kasamatsu A, Uzawa K, Nakashima D; et al. (2005). "Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines". Int. J. Mol. Med. 16 (2): 269–73. PMID 16012760.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Dai SY, Nakagawa R, Itoh A; et al. (2005). "Galectin-9 induces maturation of human monocyte-derived dendritic cells". J. Immunol. 175 (5): 2974–81. PMID 16116184.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Zhu C, Anderson AC, Schubart A; et al. (2006). "The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity". Nat. Immunol. 6 (12): 1245–52. doi:10.1038/ni1271. PMID 16286920.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• van de Weyer PS, Muehlfeit M, Klose C; et al. (2007). "A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9". Biochem. Biophys. Res. Commun. 351 (2): 571–6. doi:10.1016/j.bbrc.2006.10.079. PMID 17069754.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)